Pathogenesis of Crohn's disease

Bailliere's Clinical Gastroenterology

Volumn 12, Issue 1, 1998, Pages 1-17

  Hodgson, Humphrey J F ^a,b  

^a Department of Medicine ^*

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Cytokines; IBD aetiology; Inflammation; Mucosal immunology

Indexed keywords

ANTIGEN; CELL ADHESION MOLECULE;

ARTICLE; B LYMPHOCYTE; CROHN DISEASE; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

EID: 0031866865     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(98)90083-5     Document Type: Article

References (75)

1. Adeyemi EO & Hodgson HJF (1991) Lactoferrin: a correlate of disease activity in inflammatory bowel disease. European Journal of Gastroenterology and Hepatology 3: 51-56.
2. Adeyemi EO & Hodgson HJF (1992) Faecal elastase reflects disease activity in active ulcerative colitis. Scandinavian Journal of Gastroenterology 27: 139-142.
3. Adeyemi EO, Neumann S, Chadwick VS et al (1985) Circulating human leucocyte elastase in patients with inflammatory bowel disease. Gut 26: 1306-1311.
4. Babyatsky MW, Rossiter G & Podolsky DK (1996) Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 110: 975-984.
5. Belluzzi A, Brignola C, Campieri M et al (1996) Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. New England Journal of Medicine 13: 1557-1560.
6. Bouma G, Odukerk-Pool M, Scharenberg JG et al (1995) Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumour necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls. Scandinavian Journal of Gastroenterology 30: 1095-1100.
7. Brachle M, Madlener M, Wagner AD et al (1996) Keratinocyte growth factor is highly over-expressed in inflammatory bowel disease. American Journal of Pathology 149: 521-529.
8. Brandtzaeg P (1985) Immunopathology of Crohn's disease. Annals of Gastroenterology and Hepatology, Paris 21: 202-220.
9. Breese EJ, Michie CA, Nicholls SW et al (1994) Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106: 1455-1466.
10. Butcher EC (1991) Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67: 1033-1036.
11. Chiarpotto E, Sacvazza A, Leonarduszzi G et al (1997) Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. Free Radical Biology and Medicine 22: 889-894.
12. Cocito C, Gilot P, Coene M et al (1994) Paratuberculosis. Clinical Microbiological Review 7: 328-345.
13. Collins CE, Benson MJ, Burnham WR et al (1996) Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 10: 315-320.
14. Cominelli F, Nast CC, Clarke BD et al (1990) Interleukin-1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. Journal of Clinical Investigation 86: 972-980.
15. Cominelli F, Kam L, Casini-Raggi V et al (1994) Specific mucosal imbalance of IL-1 and IL-1 receptor antagonist (IL-1ra) in IBD: a potential mechanism of chronic inflammation. Gastroenterology 106: A667.
16. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 8: 1627-1652.
17. Duchmann R, Marker-Hermann E & Meyer-zum-Buschenfelde KH (1996) Bacteria-specific T cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease. Scandinavian Journal of Immunology 44: 71-79.
18. Duerr RH, Targen SR, Landers CJ et al (1991) Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterologe 100: 406-413.
19. van Dulleman HM, van Deventer SJ, Hommes DW et al (1995) Treatment of Crohn's disease with anti-tumour necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109: 129-135.
20. Ekbom A, Daszak P, Kraaz W et al (1996) Crohn's disease after in-utero measles virus exposure. Lancet 348: 515-517.
21. Elliott MJ, Maini RN, Feldmann M et al (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 1105-1110.
22. Emerit J, Pelletier S, Likforman J et al (1991) Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. Free Radical Research Communications 12: 563-569.
23. Fu S, Ramanujam KS, Meltzer SJ et al (1996) Inducible nitric oxide synthetase (iNOS) and cyclooxygenase (COX-2) expression in ulcerative colitis and Crohn's disease. Gastroenterology 110: A910.
24. Fukushima K, West G & Fiocchi C (1995) Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA. Comparative study of RT-PCR in biopsies and isolated cells from normal and inflamed intestine. Digestive Diseases and Sciences 40: 1498-1505.
25. Fuss IJ, Neurath M, Boirivant M et al (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. Journal of Immunology 157: 1261-1270.
26. Grottrup-Wolfers E, Moeller J, Karbach U et al (1996) Elevated cell-associated levels of interleukin 1 beta and interleukin 6 in inflamed mucosa of inflammatory bowel disease. European Journal of Clinical Investigation 26: 115-122.
27. Gulwani-Akolkar B, Akolkar PN, Minassian A et al (1996) CD4+ cell oligoclonality in Crohn's disease: evidence for an antigen-specific response. Human Immunology 48: 114-124.
28. Haga Y, Funakoshi O, Kuroe K et al (1996) Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut 38: 211-215.
29. Halstensen TS, Das KM & Brandtzaeg P (1993) Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. Gut 34: 650-657.
30. Halstensen TS, Mollnes TE, Garred P et al (1992) Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis. Gut 33: 902-908.
31. Hodgson HJ & Jewell DP (1977) Selective IgA deficiency and Crohn's disease: report of two cases. Gut 18: 644-646.
32. Hollander D, Vadheim CM, Brettholz E et al (1986) Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Annals of Internal Medicine 105: 883-885.
33. Hugot JP, Laurent-Puig P, Gower-Rousseau C et al (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379: 821-823.
34. Iizuka M, Nakagomi O, Chiba M et al (1995) Absence of measles virus in Crohn's disease. Lancet 345: 199.
35. Kett K, Rognum TO & Brandtzaeg P (1987) Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology 93: 919-924.
36. Koizumi M, King N, Lobb R et al (1992) Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 103: 840-847.
37. Kossa K, Coulthart A, Ives CT et al (1995) Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. European Journal of Gastroenterology and Hepatology 7: 783-789.
38. Kuhn R, Lohler J, Rennick D et al (1993) IL-10 deficient mice develop chronic enteroclitis. Cell 75: 263-274.
39. Lauritsen K, Laursen LS, Bukhave K et al (1988) In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis. Gastroenterology 95: 11-17.
40. Marteau P, Colombel JF, Nemeth J et al (1990) Immunological study of histologically non-involved jejunum during Crohn's disease: evidence for reduced in vivo secretion of secretory IgA. Clinical and Experimental Immunology 80: 196-201.
41. Mazlam MZ & Hodgson HJF (1992) Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 33: 773-778.
42. Mazzucchelli L, Hauser C, Zgraggen K et al (1994) Expression of interleukin 8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. American Journal of Pathology 144: 997-1007.
43. Munkholm P, Langholz E, Hollander D et al (1994) Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 35: 68-72.
44. Nielsen O, Koppen T, Rudiger N et al (1996) Involvement of interleukin 4 and -10 in inflammatory bowel disease. Digestive Diseases and Science 41: 1786-1793.
45. Niessner M & Volk BA (1995) Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clinical and Experimental Immunology 101: 428-435.
46. Ohtani H, Nakamura S, Watanabe Y et al (1992) Light and electron microscopic immunolocalization of endothelial leukocyte adhesion molecule-1 in inflammatory bowel disease. Morphological evidence of active synthesis and secretion into vascular endothelium. Virchows Archives A für Pathologie, Anatomie und Histopathologie 420: 403-409.
47. Parronchi P, Romagnani P, Annunziato F et al (1997) Type 1 T-helper cell predominance and interleukin 12 expression in the gut of patients with Crohn's disease. American Journal of Pathology 150: 823-832.
48. Pober JS & Cotran RS (1990) Cytokines and endothelial cell biology. Physiological Reviews 70: 427-451.
49. Podolsky DK, Lobb R, King N et al (1993) Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody. Journal of Clinical Investigation 92: 372-380.
50. Poulson R, Chinery R, Sarraf C et al (1993) Trefoil peptide gene expression in small intestinal Crohn's disease and dietary adaptation. Journal of Clinical Gastroenterology 17: S78-S91.
51. Prantera C, Kohn A, Mangiarotti R et al (1994) Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen. American Journal of Gastroenterology 89: 513-518.
52. Procaccino F, Reinshagen M, Hoffmann P et al (1994) Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 107: 12-17.
53. Rampton DS & Collins CE (1993) Review article: thromboxanes in inflammatory bowel disease - pathogenic and therapeutic implications. Alimentary Pharmacology and Therapeutics 7: 357-367.
54. Rask-Madsen J, Bukhave K, Laursen LS et al (1992) 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease. Agents Actions 35 Special No.: C37-46.
55. Reimund JM, Wittersheim C, Dumont S et al (1996) Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. Journal of Clinical Immunology 16: 144-150.
56. Roman LI, Manzano L, De-La-Hera A et al (1996) Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease. Gastroenterology 110: 1008-1019.
57. Rugtveit J, Brandtzaeg P, Halstensen TS et al (1994) Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 35: 669-674.
58. Sadlack B, Merz H, Schorle H et al (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261.
59. Sanderson JD, Moss MR, Tizard MLC & Hermon-Taylor J (1992) Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 33: 890-896.
60. Satsangi J, Grootscholten C, Holt H et al (1996a) Clinical patterns of familial inflammatory bowel disease. Gut 38: 738-741.
61. Satsangi J, Parkes M, Louis E et al (1996b) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genetics 14: 199-202.
62. Satsangi J, Welsh KL, Bunce M et al (1996c) Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347: 1212-1217.
63. Saverymuttu SH, Camilleri M, Rees H et al (1986) Indium-111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and faecal indium 111-granulocyte excretion. Gastroenterology 90: 1121-1128.
64. Schaufelberger HD, Uhr MR, McGuckin C et al (1994) Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors. European Journal of Clinical Investigation 24: 656-663.
65. Snook JA, Chapman RW, Fleming K et al (1989) Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clinical and Experimental Immunology 76: 30-33.
66. Stamp GW, Poulsom R, Chung LP et al (1992) Lysozyme gene expression in inflammatory bowel disease. Gastroenterology 103: 532-538.
67. Strober W & Erhardt RD (1993) Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75: 230-235.
68. Strober W, Kelsall B, Fuss I et al (1997) Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunology Today 18: 61-64.
69. Tysk C, Lindberg E, Jarnerot G et al (1988) Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29: 990-996.
70. Verspaget HW, Pena AS, Weterman IT et al (1988) Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 29: 223-228.
71. Wakefield AJ, Sankey EA, Dhillon AP et al (1991) Granulomatous vasculitis in Crohn's disease. Gastroenterology 100: 1279-1287.
72. Wakefield AJ, Ekbom A, Dhillon AP et al (1995) Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 108: 911-916.
73. Wakefield AJ, Sim R, Akbar AN et al (1997) In situ immune responses in Crohn's disease: a comparison with acute and persistent measles virus infection. Journal of Medical Virology 41: 90-100.
74. Wardle TD (1994) Interleukin 10 inhibits inflammatory mediator production in ulcerative colitis. Gut 35: S48.
75. Youngman KR, Simon PL, West GA et al (1993) Localisation of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 104: 749-758.